• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
  • Activism
  • Animal Testing
  • Artificial Intelligence
  • Boeing 737
  • Brexit
  • Cannabis
  • Censorship
  • Climate
  • Coal
  • COVID-19
  • Criminal
  • Death
  • Debt Markets
  • Derivatives
  • Diversity
  • Economy
  • Electric Vehicles
  • Electricity Generation
  • Ethanol
  • Financial
  • Firearms
  • Fossil Fuels
  • Glyphosate
  • Harassement
  • Immigration
  • Information Security
  • Intellectual Property
  • Interest Rates
  • Labor
  • Layoff
  • Lead
  • Legal
  • Palm Oil
  • Pension
  • Political
  • Product Safety
  • Regulatory
  • Religion
  • Securities Market
  • Supply Chain
  • Tariff
  • Textiles
  • US Equities
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Maze Therapeutics' CEO Sold Over 30,000 Company Shares. What Does That Mean for Investors? ↗
June 05, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers MAZE
Exposures Lead Legal Regulatory
News headline image
Caleres (CAL) Q1 2026 Earnings Call Transcript ↗
June 04, 2026
Via The Motley Fool
Topics Earnings
Tickers CAL
Exposures Financial Lead
News headline image
Enliven Therapeutics' Chief Medical Officer Sold 5,000 Company Shares. Here's What That Means for Investors. ↗
June 01, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers ELVN
Exposures Lead Legal Regulatory
News headline image
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% ↗
May 29, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers ARGX ERAS INSM MDGL PTCT PTGX
Exposures Lead Legal Regulatory
News headline image
How workforce AI and agentic AI solutions transform operations improve efficiency and scale modern business performance ↗
May 29, 2026
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence Lead
News headline image
Leadpages Pricing Shapes Smarter Lead Generation Decisions ↗
May 27, 2026
Via Talk Markets
Exposures Lead
News headline image
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing ↗
May 26, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers BSX CVS INSM LLY REGN VERA
Exposures Lead Legal Regulatory
News headline image
Champion Homes SKY Q3 2026 Earnings Transcript ↗
May 25, 2026
Via The Motley Fool
Tickers SKY
Exposures Lead
News headline image
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter ↗
May 24, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers ALMS GH GPCR IMVT PCVX TARS
Exposures Lead Legal Regulatory
News headline image
After a Q1 Blowout and a Soaring Share Price, Is AMD Stock Still a Buy? ↗
May 22, 2026
Via The Motley Fool
Topics Artificial Intelligence Earnings
Tickers AMD NVDA
Exposures Artificial Intelligence Financial Lead
News headline image
Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy? ↗
May 18, 2026
Via The Motley Fool
Tickers ABVX BEAM IMVT PTGX ROIV
Exposures Lead
News headline image
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy? ↗
May 18, 2026
Via The Motley Fool
Topics ETFs Regulatory Compliance
Tickers ABVX CRNX IMVT PTGX ROIV
Exposures Lead Legal Regulatory
News headline image
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers CELC CRVS KOD KYMR RVMD TNGX
Exposures Lead Legal Regulatory
News headline image
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers CELC KOD KYMR RVMD TNGX
Exposures Lead Legal Regulatory
News headline image
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares ↗
May 17, 2026
Via The Motley Fool
Tickers ABVX COGT MAZE PRAX SYRE
Exposures Lead
News headline image
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers ABVX COGT GPCR PRAX SYRE
Exposures Lead Legal Regulatory
News headline image
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers BBOT ERAS EWTX EYPT PRAX
Exposures Lead Legal Regulatory
News headline image
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy ↗
May 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers DRUG ERAS PRAX TERN TNGX WHWK
Exposures Lead Legal Regulatory
News headline image
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares ↗
May 16, 2026
Via The Motley Fool
Tickers ARGX COGT INSM NKTR ONC ROIV
Exposures Lead
News headline image
Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700% ↗
May 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers ERAS EWTX KYMR ONC SRRK
Exposures Lead Legal Regulatory
News headline image
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120% ↗
May 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers DNTH ELVN JBIO ORKA
Exposures Lead Legal Regulatory
News headline image
Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story ↗
May 10, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers CAPR
Exposures Lead Legal Regulatory
News headline image
Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗
May 10, 2026
Via The Motley Fool
Tickers ALMS CELC CVX KRYS TGTX XOM
Exposures Lead
News headline image
Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials ↗
May 07, 2026
Via The Motley Fool
Topics Regulatory Compliance
Tickers MAZE
Exposures Lead Legal Regulatory
News headline image
Onto (ONTO) Q1 2026 Earnings Transcript ↗
May 05, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy
Tickers ONTO
Exposures Artificial Intelligence Lead Supply Chain
News headline image
Coral Gables Lead Outreach, Prospecting & Qualification: Expert Service Announce
April 25, 2026
Via Press Release Distribution Service
Exposures Lead
News headline image
Stop Smoking Hypnosis in Orlando, FL Helps 63-Year-Old End a 40+ Year, 2-Pack-a-Day Habit After Just One Session
April 17, 2026
Via AB Newswire
Exposures Lead
News headline image
The Chicago Marketing Agency Helps Businesses Scale Faster with Data-Driven Digital Marketing Solutions
April 15, 2026
Via Get News
Exposures Lead
News headline image
Zambuki Introduces AI-Powered Roofing Leads Service for Contractors
April 15, 2026
Via Press Advantage
Topics Artificial Intelligence
Exposures Artificial Intelligence Lead
Block Co-Founder Foresees AI Doing Middle Management Tasks
April 08, 2026
Via Investor Brand Network
Topics Artificial Intelligence
Tickers QBTS
Exposures Artificial Intelligence Lead
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap